| New-onset IgG autoantibodies in hospitalized patients with COVID-19 SE Chang, A Feng, W Meng, SA Apostolidis, E Mack, M Artandi, L Barman, ... Nature communications 12 (1), 5417, 2021 | 463 | 2021 |
| Proinflammatory IgG Fc structures in patients with severe COVID-19 S Chakraborty, J Gonzalez, K Edwards, V Mallajosyula, AS Buzzanco, ... Nature immunology 22 (1), 67-73, 2021 | 302 | 2021 |
| CD8+ T cells specific for conserved coronavirus epitopes correlate with milder disease in patients with COVID-19 V Mallajosyula, C Ganjavi, S Chakraborty, AM McSween, ... Science immunology 6 (61), eabg5669, 2021 | 146 | 2021 |
| SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand? S Chakraborty, V Mallajosyula, CM Tato, GS Tan, TT Wang Advanced drug delivery reviews 172, 314-338, 2021 | 116 | 2021 |
| Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity S Chakraborty, JC Gonzalez, BL Sievers, V Mallajosyula, S Chakraborty, ... Science Translational Medicine 14 (635), eabm7853, 2022 | 106 | 2022 |
| Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses BL Sievers, S Chakraborty, Y Xue, T Gelbart, JC Gonzalez, AG Cassidy, ... Science translational medicine 14 (634), eabn7842, 2022 | 106 | 2022 |
| Protective efficacy of influenza group 2 hemagglutinin stem-fragment immunogen vaccines TC Sutton, S Chakraborty, VVA Mallajosyula, EW Lamirande, K Ganti, ... NPJ vaccines 2 (1), 35, 2017 | 52 | 2017 |
| Symptomatic SARS-CoV-2 infections display specific IgG Fc structures S Chakraborty, J Gonzalez, K Edwards, V Mallajosyula, AS Buzzanco, ... | 29 | 2020 |
| TNF-α+ CD4+ T cells dominate the SARS-CoV-2 specific T cell response in COVID-19 outpatients and are associated with durable antibodies K van der Ploeg, AS Kirosingh, DAM Mori, S Chakraborty, Z Hu, ... Cell Reports Medicine 3 (6), 2022 | 28 | 2022 |
| Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study Z Hu, K van der Ploeg, S Chakraborty, PS Arunachalam, DAM Mori, ... Elife 11, e77943, 2022 | 16 | 2022 |
| Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity. Sci. Transl. Med. 14, eabm7853 S Chakraborty, JC Gonzalez, BL Sievers, V Mallajosyula, S Chakraborty, ... | 14 | 2022 |
| Heterogeneity in IgG‐CD16 signaling in infectious disease outcomes JC Gonzalez, S Chakraborty, NK Thulin, TT Wang Immunological Reviews 309 (1), 64-74, 2022 | 13 | 2022 |
| Structurally and functionally distinct early antibody responses predict COVID-19 disease trajectory and mRNA vaccine response S Chakraborty, JC Gonzalez, BL Sievers, V Mallajosyula, S Chakraborty, ... BioRxiv, 2021.05. 25.445649, 2021 | 13 | 2021 |
| Early immune responses have long-term associations with clinical, virologic, and immunologic outcomes in patients with COVID-19 Z Hu, K van der Ploeg, S Chakraborty, P Arunachalam, D Mori, ... Research square, 2022 | 11 | 2022 |
| Differential peripheral blood glycoprotein profiles in symptomatic and asymptomatic COVID-19 C Pickering, B Zhou, G Xu, R Rice, P Ramachandran, H Huang, TD Pham, ... Viruses 14 (3), 553, 2022 | 8 | 2022 |
| Sialylated IgG induces the transcription factor REST in alveolar macrophages to protect against lung inflammation and severe influenza disease S Chakraborty, BYL Cheng, DL Edwards, JC Gonzalez, DKC Chiu, ... Immunity 58 (1), 182-196. e10, 2025 | 4 | 2025 |
| Early immune responses have long-term associations with clinical, virologic, and immunologic outcomes in patients with COVID-19. Res. Sq Z Hu, K Ploeg, S Chakraborty, P Arunachalam, D Mori, K Jacobson, ... | 2 | 2022 |
| Magnitude and breadth of neutralizing antibody responses elicited by SARS-CoV-2 infection or vaccination BL Sievers, S Chakraborty, Y Xue, T Gelbart, JC Gonzalez, AG Cassidy, ... medRxiv, 2021.12. 30.21268540, 2022 | 1 | 2022 |
| Coupling antigens from multiple subtypes of influenza can broaden antibody and T cell responses V Mallajosyula, S Chakraborty, E Sola, RF Fong, V Shankar, F Gao, ... Science 386 (6728), 1389-1395, 2024 | | 2024 |
| Calibrating T cell help by antigen cross-linking as a universal vaccine platform against rapidly evolving pathogenic viruses V Mallajosyula, S Chakraborty, E Sola, F Gao, T Wang, MM Davis The Journal of Immunology 210 (1_Supplement), 223.05-223.05, 2023 | | 2023 |
Taia T WangStanford UniversityVerified email at stanford.edu